BackgroundRecent open-label trials show that psychedelics, such as ayahuasca, hold
promise as fast-onset antidepressants in treatment-resistant depression.MethodsTo test the …

Major depression is a highly prevalent mood disorder, affecting about 350 million people, and
around 30% of the patients are resistant to currently available antidepressant medications. …

Suicide is a major public health problem. Given increasing suicide rates and limitations
surrounding current interventions, there is an urgent need for innovative interventions for …

Ayahuasca, the vine of the souls in Quechua, is a psychedelic brew with a few formulations
that most often include the bark of a liana in the Malpighiaceae family (Banisteriopsis caapi), …

Psychedelics are being increasingly examined for their therapeutic potential in mood
disorders. While the acute effects of ayahuasca, psilocybin, and lysergic acid diethylamide (LSD) …

This article proposes a real-time Head Pose Estimation (HPE) technique designed to be
used in mobile devices. The method enables the interaction between the user and mobile …

We investigated whether mood and lifestyle-related indicators of physical health are
differentially expressed according to self-reported levels of depressive symptoms among young …

Objective: Olanzapine is an atypical antipsychotic drug used to treat schizophrenia. Some of
the adverse effects related to its use are obesity, hyperlipidemia, type 2 diabetes and …

Background: Recent findings suggest that dopaminergic abnormalities found in psychotic
disorders may be secondary to nitric oxide dysfunctions. Nitric oxide seems to influence …

Esse estudo tem como objetivo descrever fatores neuropsicológicos associados a condutas
autolesivas, com base em revisão integrativa da literatura realizada através de bases de …